MYRIAD GENETICS INC (MYGN) Earnings History & Surprises
NASDAQ:MYGN • US62855J1043
5.06 USD
-0.06 (-1.17%)
At close: Mar 11, 2026
5.16 USD
+0.1 (+1.98%)
After Hours: 3/11/2026, 8:14:18 PM
Past quarterly earnings results for MYRIAD GENETICS INC (MYGN), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
Earnings Snapshot
Next Earnings Date
Release DateMay 4, 2026
PeriodQ1 / 2026
EPS Estimate-$0.08
Revenue Estimate206.35M
Last Reported
Release DateFeb 23, 2026
PeriodQ4 / 2025
EPS Reported$0.04
EPS Surprise 368.23%
Revenue Surprise -0.81%
Beat Rate
63%
EPS and Revenuebeats vs estimates
Quarterly Earnings Results
EPS & Revenue History (USD)
Actual vs estimated values, surprises, q2q growth and acceleration numbers for recent quarters.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | 0.04 | -0.01 | 368.23% | 33.33% | 209.8M | 211.51M | -0.81% | -0.38% |
| Q3 2025 | 0.00 | -0.01 | 100.00% | -100.00% | 205.7M | 208.99M | -1.57% | -3.56% |
| Q2 2025 | 0.05 | -0.01 | 627.66% | - | 213.1M | 205.91M | 3.49% | 0.76% |
| Q1 2025 | -0.03 | -0.06 | 49.87% | -200.00% | 195.9M | 204.58M | -4.24% | -3.12% |
| Q4 2024 | 0.03 | 0.03 | -2.90% | -25.00% | 210.6M | 215.85M | -2.43% | 7.12% |
| Q3 2024 | 0.06 | 0.02 | 205.26% | 300.00% | 213.3M | 214.94M | -0.76% | 11.15% |
| Q2 2024 | 0.05 | -0.01 | 500.81% | 162.50% | 211.5M | 209.05M | 1.17% | 15.26% |
| Q1 2024 | -0.01 | -0.11 | 90.66% | 95.24% | 202.2M | 197.38M | 2.44% | 11.59% |
| Q4 2023 | 0.04 | 0.01 | 208.06% | 133.33% | 196.6M | 198.68M | -1.05% | 10.57% |
| Q3 2023 | -0.03 | -0.08 | 63.74% | 84.21% | 191.9M | 182.82M | 4.97% | 22.70% |
| Q2 2023 | -0.08 | -0.09 | 7.73% | -300.00% | 183.5M | 190.87M | -3.86% | 2.34% |
| Q1 2023 | -0.21 | -0.20 | -6.49% | -600.00% | 181.2M | 174.98M | 3.55% | 9.88% |
| Q4 2022 | -0.12 | -0.17 | 27.97% | -500.00% | 177.8M | 172.85M | 2.86% | 10.57% |
| Q3 2022 | -0.19 | -0.06 | -210.46% | -850.00% | 156.4M | 173.5M | -9.86% | -6.52% |
| Q2 2022 | 0.04 | 0.01 | 292.16% | -66.67% | 179.3M | 174.42M | 2.80% | -5.33% |
| Q1 2022 | -0.03 | -0.07 | 56.19% | 50.00% | 164.9M | 159.76M | 3.22% | -4.74% |
| Q4 2021 | -0.02 | -0.02 | 15.95% | 83.33% | 160.8M | 166.67M | -3.52% | 4.01% |
| Q3 2021 | -0.02 | -0.02 | 1.96% | 93.41% | 167.3M | 168.34M | -0.62% | 15.22% |
| Q2 2021 | 0.12 | -0.09 | 235.38% | 125.27% | 189.4M | 168.42M | 12.46% | 103.22% |
| Q1 2021 | -0.06 | -0.14 | 57.60% | -884.31% | 173.1M | 159.33M | 8.64% | 5.55% |
| Q4 2020 | -0.12 | -0.13 | 4.61% | - | 154.6M | 153.4M | 0.78% | - |
| Q3 2020 | -0.30 | - | - | 145.2M | 137.242M | 5.80% | - | |
| Q2 2020 | -0.47 | - | - | 93.2M | 95.26M | -2.16% | - | |
| Q1 2020 | 0.01 | - | - | 164M | 169.893M | -3.47% | - |
Notes
- EPS and Revenue values are non-GAAP when available, otherwise GAAP.
- Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
- Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
- Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.
Earnings Q2Q Performance Trends
EPS Historical Q2Q growth and Acceleration
Revenue Historical Q2Q growth and Acceleration
Surprise distribution (Last 4 Quarters)
EPS beat statistics
EPS beat (4)
4
Average EPS beat (4)
286.44%
Max EPS beat (4)
627.66%
Min EPS beat (4)
49.87%
Revenue beat statistics
Revenue beat (4)
1
Average Revenue beat (4)
-0.78%
Max Revenue beat (4)
3.49%
Min Revenue beat (4)
-4.24%
Analysis
In the last 4 quarters, MYGN has consistently beaten EPS estimates in all releases
MYGN has beaten revenue estimates in 1 out of the last 4 releases
In the last 4 quarters, MYGN has beaten the EPS estimates by 286.4% on average.
In the last 4 quarters, MYGN reported -0.8% below the revenue estimates on average.
MYRIAD GENETICS INC / MYGN Earnings FAQ
When did MYRIAD GENETICS INC (MYGN) report earnings last quarter?
MYRIAD GENETICS INC (MYGN) last reported earnings on 2/23/2026.
Did MYRIAD GENETICS INC (MYGN) beat earnings estimates last quarter?
MYRIAD GENETICS INC (MYGN) beat EPS estimates and missed revenue estimates in the most recent quarter.
How often does MYRIAD GENETICS INC (MYGN) beat earnings estimates?
In the last 4 quarters, MYRIAD GENETICS INC (MYGN) has beaten EPS estimates in 4 out of 4 releases.